New Delhi, Aug. 14 -- As the Molbio Diagnostics IPO concluded with a strong subscription of 70 times on Wednesday, and share allotment was finalised on Thursday, investors who bid on the issue await the listing of the stock on the NSE and the BSE, scheduled for Monday, 17 August.

Investors who placed bids in the IPO can check the share allotment on the issue registrar's website, the BSE, and the NSE. KFin Technologies was the registrar of the issue.

Meanwhile, grey market sources suggest the stock could debut at a healthy premium over the issue price, even as stock market sentiment remains cautious amid oil price volatility driven by lingering uncertainty over the reopening of the Strait of Hormuz.

The latest grey market premium (GMP) ...